Prefer to start with semaglutide
The FDA has given compounders time to wind down semaglutide copies, saying it wont take enforcement actions against a category of state-licensed compounders until April 22 and wont take actions against another category known as outsourcing facilities until May 22
Evaluate Vantage reports Eli Lilly admitted orforglipron wont be as powerful as Mounjaro because the former is just a GLP-1 receptor agonist, whereas Mounjaro is a GLP-1 receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor drug
This all helps to lower blood sugar levels and HbA1c, improving your glycaemic control as well as having a secondary effect on your weight
Medications such as Ozempic slow digestion, lower blood sugar, and keep hunger levels at bay by maintaining a feeling of fullness between meals
Gastrointestinal side effects like nausea, constipation, or stomach pain are most common when you first start the medication or after a dose increase
.png)
